tiprankstipranks
Trending News
More News >
Mangalam Drugs & Organics Ltd. (IN:MANGALAM)
:MANGALAM
India Market
Advertisement

Mangalam Drugs & Organics Ltd. (MANGALAM) Financial Statements

Compare
0 Followers

Mangalam Drugs & Organics Ltd. Financial Overview

Mangalam Drugs & Organics Ltd.'s market cap is currently ₹1.36B. The company's EPS TTM is ₹0.04; its P/E ratio is 20.18; Mangalam Drugs & Organics Ltd. is scheduled to report earnings on May 17, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 3.18B₹ 3.67B₹ 3.70B₹ 4.47B₹ 3.80B
Gross Profit₹ 1.50B₹ 188.12M₹ 287.77M₹ 546.89M₹ 976.69M
Operating Income₹ 192.16M₹ 10.47M₹ 149.65M₹ 388.05M₹ 444.47M
EBITDA₹ 358.23M₹ 139.86M₹ 259.54M₹ 451.84M₹ 550.15M
Net Income₹ 67.21M₹ -90.72M₹ 12.70M₹ 196.57M₹ 279.71M
Balance Sheet
Cash & Short-Term Investments₹ 25.89M₹ 11.87M₹ 26.88M₹ 19.55M₹ 5.92M
Total Assets₹ 3.66B₹ 3.34B₹ 3.60B₹ 3.28B₹ 2.64B
Total Debt₹ 962.30M₹ 1.07B₹ 885.47M₹ 879.04M₹ 697.06M
Net Debt₹ 936.41M₹ 1.06B₹ 858.66M₹ 859.58M₹ 691.22M
Total Liabilities₹ 2.17B₹ 1.98B₹ 2.08B₹ 1.78B₹ 1.33B
Stockholders' Equity₹ 1.49B₹ 1.36B₹ 1.52B₹ 1.51B₹ 1.31B
Cash Flow
Free Cash Flow₹ 223.93M₹ -79.20M₹ 116.09M₹ -19.60M₹ -38.86M
Operating Cash Flow₹ 425.94M₹ 39.13M₹ 395.23M₹ 257.09M₹ 275.50M
Investing Cash Flow₹ -194.72M₹ -118.27M₹ -221.72M₹ -273.26M₹ -312.85M
Financing Cash Flow₹ -217.12M₹ 52.27M₹ -166.17M₹ 29.79M₹ 26.98M
Currency in INR

Mangalam Drugs & Organics Ltd. Earnings and Revenue History

Mangalam Drugs & Organics Ltd. Debt to Assets

Mangalam Drugs & Organics Ltd. Cash Flow

Mangalam Drugs & Organics Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis